CMS Releases Guidance to States on the Food and Drug Administration’s Final Regulation Revising Section 804 of the Federal Food Drug and Cosmetic Act (FFDCA) on Reimported Drugs and the Medicaid Drug Rebate Program

View in browser | Distributed by Center for Medicaid and CHIP Services (CMCS)

Today, the Centers for Medicare & Medicaid Services released guidance to states discussing the Food and Drug Administration’s Importation of Prescription Drugs final rule that is revising Section 804 of the Federal Food Drug and Cosmetic Act (FFDCA) and the implications of this regulation on the Medicaid Drug Rebate Program (MDRP).  Specifically, this guidance addresses: States implementation of this final rule; Importation Requirements; and Implications for MDRP. 

 To learn more about this guidance please use the link below:

• Medicaid Drug Rebate Program Notice on FDA Final Regulation Revising Section 804 of the Federal Food Drug and Cosmetic Act (FFDCA) on Reimported Drugs and the Medicaid Drug Rebate Program